Harmful errors in radiology suite top national database

Article

The number of reported medication errors associated with radiological services is relatively small. The percentage of errors that result in patient harm, however, is alarmingly high, according to a report released in January by the United States Pharmacopeia.

The number of reported medication errors associated with radiological services is relatively small. The percentage of errors that result in patient harm, however, is alarmingly high, according to a report released in January by the United States Pharmacopeia.

Of the 2032 reported medication errors that occurred in radiological services between 2000 and 2004, 12% were categorized as harmful. This percentage is seven times higher than the percentage of harm seen in the overall USP data for the same five-year period, said lead author John P. Santell, director of USP educational program initiatives.

The American College of Radiology took issue with the report and its inclusion of errors occurring in cardiac cath labs. Fewer than 1% of all cardiac cath procedures are performed by radiologists. These labs had the highest percentage (40%) of medication errors cited in the report. Other areas reviewed were radiology and nuclear medicine.

The ACR also noted that the error rate of 0.00008% is more than 3700 times better than the lowest hospital-wide medication error rate (0.3%) cited by a recent Institute of Medicine report on this issue.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.